These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 29203493)

  • 21. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Area-Under-Curve-Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis.
    Lim AS; Foo SHW; Benjamin Seng JJ; Magdeline Ng TT; Chng HT; Han Z
    Ther Drug Monit; 2023 Aug; 45(4):519-532. PubMed ID: 36728329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Vancomycin Bayesian-Estimated Area Under the Curve Versus Trough-Based Dosing.
    Cerenzio J; Truong J
    Ann Pharmacother; 2023 Aug; 57(8):931-939. PubMed ID: 36476049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
    Reilly AM; Ding MX; Rower JE; Kiser TH
    J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
    Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis.
    Morales Junior R; Tiguman GMB; D'Amaro Juodinis V; Santos ICPF; Leite FS; Vercelino JG; de Lima BD; Barbosa LMG
    Clin Ther; 2022 Sep; 44(9):e91-e96. PubMed ID: 36031477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K; Crumby AS; Maples HD
    Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of area under the concentration-time curve-guided vancomycin dosing with or without piperacillin-tazobactam on the incidence of acute kidney injury.
    Muklewicz JD; Steuber TD; Edwards JD
    Int J Antimicrob Agents; 2021 Jan; 57(1):106234. PubMed ID: 33232734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
    Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Open-Access, Trough-Only Online Calculators Versus Trapezoidal Method for Calculation of Vancomycin Area Under the Curve (AUC).
    Keil E; Wrenn RH; Deri CR; Slaton CN; Shroba J; Parish A; Erkanli A; Spivey J
    Ann Pharmacother; 2023 Aug; 57(8):940-947. PubMed ID: 36453697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Vancomycin Area Under the Concentration-Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment.
    Kim HK; Jeong TD
    Ann Lab Med; 2023 Nov; 43(6):554-564. PubMed ID: 37387488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
    Horita Y; Asaoka M; Iida M; Kato H; Wachino C; Mitamura K; Ohashi K; Mimura Y; Hotta Y; Kataoka T; Nakamura A; Kimura K
    Ther Drug Monit; 2023 Apr; 45(2):245-250. PubMed ID: 36006610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the Clinical Use of Vancomycin.
    Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
    Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model-Informed Precision Dosing Improves Outcomes in Patients Receiving Vancomycin for Gram-Positive Infections.
    Hall NM; Brown ML; Edwards WS; Oster RA; Cordell W; Stripling J
    Open Forum Infect Dis; 2024 Jan; 11(1):ofae002. PubMed ID: 38250202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient.
    Moffett BS; Ivaturi V; Morris J; Akcan Arikan A; Dutta A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
    Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
    Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.